Publications

5677 Results

Association of DNA damage response (DDR) gene alterations (alts) and response to neoadjuvant cisplatin-based chemotherapy (chemo) in muscle-invasive bladder cancer (MIBC) patients (pts) enrolled onto SWOG S1314

Authors
G Iyer;C Tangen;M Sarfaty;A Regazzi;IM Thompson;D McConkey;T Flaig;J Rosenberg
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 4522), poster 14; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
S1314

A Pragmatic Cluster-Randomized Trial of a Standing Physician Order Entry Intervention for Colony Stimulating Factor use among Patients at Intermediate Risk for Febrile Neutropenia (SWOG S1415CD)

Authors
DL Hershman;A Bansal;S Sullivan;G Lyman;W Barlow;K Arnold;K Watabayashi;A Bell-Brown;N Le-Lindqwister;C Dul;U Brown-Glaberman;R Behrens;V Vogel;N Alluri;SD Ramsey
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 1518), poster 112; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1415CD

A pragmatic cluster-randomized trial of a computerized clinical decision support system to improve colony stimulating factor prescribing for cancer patients receiving myelosuppressive chemotherapy (SWOG S1415CD)

Authors
S Ramsey;A Bansal;S Sullivan;G Lyman;W Barlow;K Arnold;K Watabayashi;A Bell-Brown;N Le-Lindqwister;C Dul;U Brown-Glaberman;R Behrens;V Vogel;N Alluri;D Hershman
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 1525), poster 119; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1415CD

Cell-free DNA methylation as a predictive biomarker of response to neoadjuvant chemotherapy for patients with muscle invasive bladder cancer in SWOG S1314

Authors
Y-T Lu;M Plets;G Morrison;A Cunha;S Cen;S Rhie;K Siegmund;S Daneshmand;D Quinn;S Lerner;D Petrylak;D McConkey;T Flaig;I Thompson;A Goldkorn
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 4506), abst 4506; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL), oral
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
S1314

A Phase III Randomized Trial of Eribulin (E) with or without Gemcitabine vs Standard of Care (SOC) for Metastatic Urothelial Carcinoma (UC) Refractory to or Ineligible for PD/PDL1 Antibody (Ab): SWOG S1937 (ClinicalTrials.gov NCT04579224)

Authors
S Sadeghi;M Plets;P Lara;C Tangen;R Bangs;S Lerner;T Flaig;D Petrylak;IM Thompson
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr TPS4608), poster 94a; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
S1937

Impact of Social Media on the Wellness of Pediatric and Adult Oncologists: A SWOG and COG survey

Authors
S Moerdler;M Barry;E Henry;T Lucas;A Marshall;D Dizon
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 11013), poster 204; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022

National impact of the COVID-19 pandemic on clinical trial staff attrition: Results of the SWOG Cancer Research Network survey of Oncology Research Professionals

Authors
D Dizon;C Szczepanek;D Petrylak;D Sparks;C Tangen;P Lara;IM Thompson;CD Blanke
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 11049), poster 240; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022

Assessing Intermediate Clinical Endpoints (ICE) as Potential Surrogates for Overall Survival (OS) in men with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Authors
S Halabi;A Roy;L Rydzewska;P Godolphin;M Parmar;M Hussain;C Tangen;I Thompson;W Xie;M Carducci;M Smith;M Morris;G Gravis;D Dearnaley;P Verhagen;T Goto;N James;M Buyse;J Tierney;C Sweeney
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 5006), abst 5006; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL), oral
Year
2022
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Vitamin D Insufficiency as a Peripheral Neuropathy Risk Factor in White and Black Patients in SWOG 0221

Authors
C-S Chen;G Zirpoli;S McCann;W Barlow;GT Budd;L Pusztai;G Hortobagyi;A Godwin;A Thompson;C Ambrosone;K Stringer;D Hertz
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 12023), poster 269; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Breast
Study Number(s)
S0221

Prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer (SWOG S0800) using image analysis-based tumor infiltrating lymphocyte measurements

Authors
K Blenman;K Fanucci;Y Bai;V Pelekanou;Z Nahleh;S Shafi;S Burela;W Barlow;P Sharma;A Thompson;A Godwin;D Rimm;G Hortobagyi;L Pusztai
Journal / Conference
J Clin Oncol 40, 2022 (suppl 16; abstr 594), poster 365; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
Year
2022
Research Committee(s)
Breast
Study Number(s)
S0800